The novel diagnostic marker in low-LVEF heart failure patients

• Published in: Bratislavské lékarské listy Vol. 119; no. 7; pp. 421 - 424
• Main Authors: Demir, S, Ede, H, Kaplan, M, Yavuz, F, Yucel, C, Kurt, I H
• Format: Journal Article
• Language: English
• Published: Slovakia 2018
• Subjects: PIP; BNP hs-CRP
• ISSN: 0006-9248
• DOI: 10.4149/BLL_2018_076

The structural and compositional changes in the myocardium seem to have a major role in the development of heart failure (HF).Imbalance between production and degradation in extracellular collagen results in increase of collagen synthesis biomarkers in the circulation as the carboxy-terminal propeptide of type I procollagen (PIP). Here we aimed to determine role of PIP in the diagnosis of chronic HF. 87 patients with HF group and 80 healthy subjects were enrolled into the study. Echocardiographic examination was performed.At the beginning of the study, serum B type natriuretic peptide (BNP), PIP, high sensitive C-reactive protein (hs-CRP) were measured . The subjects were followed for one year then after. Average PIP value of HF group was significantly higher than that of the control group (p < 0.001). Both hs-CRP and BNP values were well correlated to PIP values (p < 0.001). In the HF group, PIP value of patients who died at the end of one year was similar to that of patients who survived at the end of first year. PIP may not mirror acute events in follow-up of chronic heart failure but it is a very beneficial biomarker in diagnosis of low-LVEF heart failure with high sensitivity and specificity (Tab. 2, Fig. 1, Ref. 16).